Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Alliance to Develop New DNA Diagnostic Tools

By HospiMedica staff writers
Posted on 22 Mar 2001
A broad five-year alliance in the field of DNA-based diagnostics has been formed by deCode genetics (Reykjavik, Iceland) and Roche Diagnostics (Basel, Switzerland). More...
The alliance builds on decode's unique population genomics resources and bioinformatics expertise and on the global leadership of Roche in the field of molecular diagnostics.

The two companies will use the genomics research and informatics of decode to develop an integrated suite of new diagnostic products and services for diagnosing common diseases and for predicting individual predisposition. The partners will also develop point-of-care informatics products and services that will help doctors evaluate DNA-based test results, in order to optimize the early treatment and prevention of disease.

"By bringing together our research programs and market leadership with deCode's integrated approach to the genetics of common diseases, we hope to create a new paradigm for the use of DNA-based diagnostics in the treatment and prevention of these diseases,” said Heino von Prondzynski, head of Roche Diagnostics.



Related Links:
Roche Diagnostics
deCode genetics

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: Adobe Stock

Blood Biomarkers Help Assess Growth Risks During Steroid Treatment in Duchenne Muscular Dystrophy

Children with Duchenne muscular dystrophy (DMD) commonly receive long-term corticosteroids to slow disease progression, but these drugs can impair linear growth and weaken bone. Understanding how specific... Read more

Molecular Diagnostics

view channel
Image: The Xpert Hemorrhagic Fever Panel test runs on Cepheid’s GeneXpert Dx systems (Photo courtesy of Cepheid)

WHO Emergency Listing Supports Rapid Molecular Testing for Ebola Outbreak Response

The Democratic Republic of the Congo is confronting an Ebola Bundibugyo outbreak that the World Health Organization (WHO) designated a Public Health Emergency of International Concern on May 17, 2026.... Read more

Microbiology

view channel
Image Credit: Adobe Stock

Gut Microbiome Classifier Improves Colorectal Cancer Risk Stratification

Colorectal cancer remains a leading cause of cancer mortality, and current noninvasive screening methods still miss many precancerous lesions. Clinicians therefore need tools that improve risk stratification... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.